MP Healthcare Venture Management
Home About Us Portfolio News Contact
HomeAbout UsPortfolioNewsContact
MP Healthcare Venture Management
LiberoThera Closes 535 Million JPY Financing to Develop GPCR-targeting Therapeutics
Guest UserMay 14, 2021
Facebook0 Twitter LinkedIn0 Reddit 0 Likes
Previous

EditForce completed fund raising by third-party allotment and AMED adopts our program

Guest UserJune 30, 2021
Next

BIOGEN AND CAPSIGEN ANNOUNCE COLLABORATION TO DISCOVER AND DEVELOP NOVEL AAV CAPSIDS FOR TARGETED CNS AND NEUROMUSCULAR DISORDERS

Guest UserMay 10, 2021

© 2010-2025 MP Healthcare Venture Management, Inc.
All Rights Reserved.

Privacy Policy | Terms of Use

About UsPortfolioNews Contact